Mangalam Drugs And Organics Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
MANGALAM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mangalam Drugs and Organics has informed the exchanges that its trading window will remain closed for designated persons and their immediate relatives starting January 1, 2026. The window will reopen only 48 hours after the company declares its un-audited financial results for the quarter and nine months ended December 31, 2025. This is a standard compliance measure under SEBI's insider trading regulations to prevent insiders from trading while in possession of unpublished financial information. The closure signals that the company's Q3 FY26 results announcement is imminent.
This is a routine regulatory filing and does not directly impact shareholders. However, it tells investors that the company is preparing to release its December quarter results shortly, which could be a catalyst for stock movement depending on the numbers reported.